25
Views
0
CrossRef citations to date
0
Altmetric
Editorial

The treatment of Helicobacterpylori infection: the changing picture of a still unresolved problem

&
Pages 991-994 | Published online: 17 Aug 2006

Bibliography

  • MALFERTHEINER P, MEGRAUD F, MORAIN CO et al.: Current concepts in the management of Helicobacter pylori infection. The Maastricht 2 – 2000 Consensus Report. Aliment. Pharmacol. Ther. (2002) 16:167-180.
  • MORGNER A, LABENZ J, MIEHLKE S: Effective regimens being investigated for Helicobacter pylori infection. Expert Opinion. Investig. Drugs (2006) 15(9):995-1015.
  • LAHEEIJ RJ, ROSSUM LG, JANSEN JB, STRAATMAN H, VERBEEK AL: Evauation of treatment regimens to cure Helicobacter pylori infection – a meta-analysis. Aliment. Pharmacol. Ther. (1999) 13:857-864.
  • FURUTA T, SHIRAI N, TAKASHIMA M et al.: Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clin. Pharmacol. Ther. (2001) 69:158-168.
  • DOJO M, AZUMA T, SAITO T, OHTANI M, MURAMATSU A, KURIVAMA M: Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxicillin and clarithromycin in Japan. Dig. Liver Dis. (2001) 33:671-675.
  • HSU PI, LAI KH, LIN CK et al.: A prospective randomised trial of esomeprazole- versus patoprazole-based triple therapy for Helicobacter pylori eradication. Am. J. Gastroenterol. (2005) 100:2387-2392.
  • VERGARA M, VALLVE M, GISBERT JP, CALVET X: Meta-analysis: comparative efficacy of different proton pump inhibitors in triple therapy for Helicobacter pylori eradication. Aliment. Pharmacol. Ther. (2003) 18:647-654.
  • MANES G, PIERAMICO O, PERRI F et al.: Twice daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomised controlled trial using standard and double doses of omeprazole within a triple therapy. Dig. Dis. Sci. (2005) 50:443-448.
  • ZULLO A, VAIRA D, VAKIL N et al.: High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment. Pharmacol. Ther. (2003) 17:719-726.
  • PARENTE F, CUCINO C, BIANCHI PORRO G: Treatment options for patients with Helicobacter pylori infection resistano to one or more eradication attempts. Dig. Liver Dis. (2003) 35:523-528.
  • GISBERT JP, DELAMORENA F: Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment. Pharmacol. Ther. (2006) 23:35-44.
  • DI MARIO F, ARAGONA G, DAL BO N et al.: Use of lactoferrin for Helicobacter pylori eradication. Dig. Liver Dis. (2003) 35:706-710.
  • ZULLO A, DE FRANCESCO V, SCACCIANOCE G et al.: Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study. Dig. Liver Dis. (2005) 37:496-500.
  • CANDUCCI F, CREMONINI F, ARMUZZI A et al.: Probiotics and Helicobacter pylori eradications. Dig. Liver Dis. (2002) 34(Suppl. 2):S81-S83.
  • ZULLO A, HASSAN C, DE FRANCESCO V et al.: A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication. Dig. Liver Dis. (2003) 35:232-236.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.